Publications: Raguraman, Prithi

Journal Article

Gimenez Molina, A., Raguraman, P., Delcomyn, L., Veedu, R.N. and Nielsen, P. (2022) Oligonucleotides containing 2′-O-methyl-5-(1-phenyl-1,2,3-triazol-4-yl)uridines demonstrate increased affinity for RNA and induce exon-skipping in vitro. Bioorganic & Medicinal Chemistry, 55 . Art. 116559.

Su, Y., Raguraman, P., Veedu, R.N. and Filichev, V.V. (2022) Phosphorothioate modification improves exon-skipping of antisense oligonucleotides based on sulfonyl phosphoramidates in mdx mouse myotubes. Organic & Biomolecular Chemistry (18).

Raguraman, P., Balachandran, A.A., Chen, S., Diermeier, S.D. and Veedu, R.N. (2021) Antisense oligonucleotide-mediated splice switching: Potential therapeutic approach for cancer mitigation. Cancers, 13 (21). Article 5555.

Raguraman, P., Wang, T., Ma, L., Jørgensen, P.T., Wengel, J. and Veedu, R.N. (2020) Alpha-l-Locked nucleic acid-modified antisense oligonucleotides induce efficient splice modulation in vitro. International Journal of Molecular Sciences, 21 (7). Article 2434.

Le, B.T., Raguraman, P., Kosbar, T.R., Fletcher, S., Wilton, S.D. and Veedu, R.N. (2018) Antisense oligonucleotides targeting angiogenic factors as potential cancer therapeutics. Molecular Therapy - Nucleic Acids, 14 (1). pp. 142-157.